year,stock,source,target,sublist.holder,sublist.location,sublist.is_coreSource,sublist.table_source1,sublist.table_source2,sublist.table_source3,sublist.table_source4,market,group,taxcode.source,taxcode.target,china.note,X1,修正,非集團
2016,1783,和康生物科技股份有限公司,Maxigen Biotech International Investment Corporation Limited,1,薩摩亞,0,1,0,0,0,上市,G8355,16749811,NA,NA,NA,NA,NA
2016,1783,環宇投資股份有限公司,和康生物科技股份有限公司,NA,NA,0,0,0,0,1,上市,G8355,22663544,16749811,NA,NA,NA,NA
2016,1783,中加投資發展股份有限公司,和康生物科技股份有限公司,NA,NA,0,0,0,0,1,上市,G8355,22853571,16749811,NA,NA,NA,NA
2016,1783,環宇財務顧問股份有限公司,和康生物科技股份有限公司,NA,NA,0,0,0,0,1,上市,G8355,22858914,16749811,NA,NA,NA,NA
2016,1783,再投資大陸公司,浙江和康生物科技有限公司,0,china,0,0,0,1,0,上市,G8355,NA,NA,1,NA,NA,NA
2016,1783,Maxigen Biotech International Investment Corporation Limited,鼎石貿易(上海)有限公司,1,china,0,1,0,1,0,上市,G8355,NA,NA,NA,NA,NA,NA
2016,1783,再投資大陸公司,薩摩亞和康生物科技國際投資股份有限公司上海代表處,0,china,0,0,0,1,0,上市,G8355,NA,NA,1,NA,NA,NA
